Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1573-4919

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells ; day:27 ; month:10 ; year:2022 ; pages:1-17
Molecular and cellular biochemistry ; (27.10.2022), 1-17

Creator: Jones, Dylan
Whitehead, Clarissa A.
Dinevska, Marija
Widodo, Samuel S.
Furst, Liam M.
Morokoff, Andrew P.
Kaye, Andrew H.
Drummond, Katharine J.
Mantamadiotis, Theo
Stylli, Stanley S.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s11010-022-04584-0

URN: urn:nbn:de:101:1-2023011221032088072279

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Jones, Dylan
Whitehead, Clarissa A.
Dinevska, Marija
Widodo, Samuel S.
Furst, Liam M.
Morokoff, Andrew P.
Kaye, Andrew H.
Drummond, Katharine J.
Mantamadiotis, Theo
Stylli, Stanley S.
SpringerLink (Online service)

Other Objects (12)

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Repurposing FDA-approved drugs for anti-aging therapies

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

Repurposing of approved cardiovascular drugs

Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation

The First FDA-Approved Antibody-Drug Conjugate

Related objects

Reset password